Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FAA00
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,364
Award facts
- Contract value 100% obligated
- $5,363.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,363.80 to AmerisourceBergen Drug Corp on January 22, 2026, for pharmaceutical products to support federal medical supply needs. This firm fixed-price contract, with an ultimate completion date of January 23, 2026, is being performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded transaction issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999.99 million and extends through December 2026. This prime IDC vehicle provides comprehensive pharmaceutical support globally, enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to military healthcare systems and other federal medical institutions.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., the parent organization that also holds a larger IDC with the Defense Logistics Agency valued up to $999.99 million through December 31, 2031. The company functions as a critical vendor in the federal pharmaceutical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As AmerisourceBergen holds no set-aside designation, all contract awards are competitively awarded, demonstrating the company's capability to meet federal procurement requirements in open competition. The delivery order issued under this contract represents routine pharmaceutical procurement to support ongoing military healthcare operations and readiness.
Quick answers
Who was awarded contract SPE2DU26FAA00?
SPE2DU26FAA00 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DU26FAA00 worth?
The government has obligated $5,364 on SPE2DU26FAA00.
Is contract SPE2DU26FAA00 an order under another contract?
Yes. SPE2DU26FAA00 is a delivery order under SPE2DU25D1058, an indefinite delivery contract.
Was contract SPE2DU26FAA00 competed?
The extent of competition for SPE2DU26FAA00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award